Search

Your search keyword '"Bacteriocins metabolism"' showing total 75 results

Search Constraints

Start Over You searched for: Descriptor "Bacteriocins metabolism" Remove constraint Descriptor: "Bacteriocins metabolism" Publisher elsevier Remove constraint Publisher: elsevier
75 results on '"Bacteriocins metabolism"'

Search Results

1. Combined analysis of transcriptomics and metabolomics provide insights into the antibacterial mechanism of bacteriocin XJS01 against multidrug-resistant Staphylococcus aureus.

2. Ribosomally synthesized bacteriocins of lactic acid bacteria: Simplicity yet having wide potentials - A review.

3. Screening, probiotic properties, and inhibition mechanism of a Lactobacillus antagonistic to Listeria monocytogenes.

4. Quantitative proteomics analysis of bacteriocin-like substance producing Lactococcus spp. in simulated vegetable and fruit media.

5. Regulation of maltocin synthesis in Stenotrophomonas maltophilia by positive and negative regulators.

6. Bioconversion of antifungal viridin to phytotoxin viridiol by environmental non-viridin producing microorganisms.

7. Suitability of lactic acid bacteria and deriving antibacterial preparations to enhance shelf-life and consumer safety of emulsion type sausages.

8. Inhibition of Listeria monocytogenes by the Staphylococcus capitis - derived bacteriocin capidermicin.

9. Mining, heterologous expression, purification and characterization of 14 novel bacteriocins from Lactobacillus rhamnosus LS-8.

10. The mannose phosphotransferase system (Man-PTS) - Mannose transporter and receptor for bacteriocins and bacteriophages.

11. Bacteriocin enterocin CRL35 is a modular peptide that induces non-bilayer states in bacterial model membranes.

12. Analysis of interactions between cinnamycin and biomimetic membranes.

13. Targeting phosphatidylethanolamine and phosphatidylserine for imaging apoptosis in cancer.

14. Multifaceted ABC transporters associated to microcin and bacteriocin export.

15. Antimicrobial peptide arrays for wide spectrum sensing of pathogenic bacteria.

16. Insights into Chagas treatment based on the potential of bacteriocin AS-48.

17. PrfA activation in Listeria monocytogenes increases the sensitivity to class IIa bacteriocins despite impaired expression of the bacteriocin receptor.

18. Gene expression analysis in the potent bactericidal activity of sitafloxacin against Streptococcus pneumoniae.

19. [ 99m Tc]Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy.

20. Impact of Lactobacillus curvatus 54M16 on microbiota composition and growth of Listeria monocytogenes in fermented sausages.

21. Functions and emerging applications of bacteriocins.

22. Characterization of Enterococcus durans 152 bacteriocins and their inhibition of Listeria monocytogenes in ham.

23. Impairment of the class IIa bacteriocin receptor function and membrane structural changes are associated to enterocin CRL35 high resistance in Listeria monocytogenes.

24. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.

25. Potential of bacteriocin-producing lactic acid bacteria for safety improvements of traditional Thai fermented meat and human health.

26. Bacteriocin production and inhibition of Listeria monocytogenes by Lactobacillus sakei subsp. sakei 2a in a potentially synbiotic cheese spread.

27. Genome level analysis of bacteriocins of lactic acid bacteria.

28. Improving safety of salami by application of bacteriocins produced by an autochthonous Lactobacillus curvatus isolate.

29. The feasibility of imaging myocardial ischemic/reperfusion injury using (99m)Tc-labeled duramycin in a porcine model.

30. In vivo detection of hyperoxia-induced pulmonary endothelial cell death using (99m)Tc-duramycin.

31. Effect of autochthonous bacteriocin-producing Lactococcus lactis on bacterial population dynamics and growth of halotolerant bacteria in Brazilian charqui.

32. Dissecting the catalytic and substrate binding activity of a class II lanthipeptide synthetase BovM.

33. Inhibition of Escherichia coli O157:H7 and Salmonella enterica on spinach and identification of antimicrobial substances produced by a commercial Lactic Acid Bacteria food safety intervention.

34. Lactobacillus salivarius: bacteriocin and probiotic activity.

35. Expanded genetic code for the engineering of ribosomally synthetized and post-translationally modified peptide natural products (RiPPs).

36. Biochemical, antimicrobial and molecular characterization of a noncytotoxic bacteriocin produced by Lactobacillus plantarum ST71KS.

37. Strategies to improve the bacteriocin protection provided by lactic acid bacteria.

38. High-salt brines compromise autoinducer-mediated bacteriocinogenic Lactobacillus plantarum survival in Spanish-style green olive fermentations.

39. Heterologous expression and engineering studies of labyrinthopeptins, class III lantibiotics from Actinomadura namibiensis.

40. Inhibition of Listeria monocytogenes by Enterococcus mundtii isolated from soil.

41. Purification and characterization of a new bacteriocin active against Campylobacter produced by Lactobacillus salivarius SMXD51.

42. Application of bacteriocinogenic Enterococcus mundtii CRL35 and Enterococcus faecium ST88Ch in the control of Listeria monocytogenes in fresh Minas cheese.

43. Antimicrobial activity of pediocin PA-1 against Oenococcus oeni and other wine bacteria.

44. Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent (99m)Tc-Duramycin.

45. Lyophilized Carnobacterium divergens AS7 bacteriocin preparation improves performance of broiler chickens challenged with Clostridium perfringens.

46. Discovery of novel biopreservation agents with inhibitory effects on growth of food-borne pathogens and their application to seafood products.

47. Characterization of Lactobacillus isolates from fermented olives and their bacteriocin gene profiles.

48. Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate.

49. Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli.

50. Intermedilysin induces EGR-1 expression through calcineurin/NFAT pathway in human cholangiocellular carcinoma cells.

Catalog

Books, media, physical & digital resources